FDA Import Refusal AEK-4597176-7/31/1 — AbbVie Inc.
The FDA refused shipment AEK-4597176-7/31/1 from AbbVie Inc. (United States) on Feb 22, 2024. The refused product falls under Drugs and Biologics — LEUPROLIDE ACETATE (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Feb 22, 2024
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62ICK86 LEUPROLIDE ACETATE (ANTI-NEOPLASTIC)
- Charges
- 75